Methylene Blue in the Treatment of Neuropsychiatric Disorders Martin Alda Leading Article 29 May 2019 Pages: 719 - 725
Neurological and Psychiatric Adverse Effects of Antimicrobials Madison K. BangertRodrigo Hasbun Review Article 18 July 2019 Pages: 727 - 753
Branched-Chain Amino Acids and Seizures: A Systematic Review of the Literature Shaun E. GruenbaumEric C. ChenTore Eid Systematic Review 16 July 2019 Pages: 755 - 770
Intravenous Brivaracetam in the Treatment of Status Epilepticus: A Systematic Review Francesco BrigoSimona LattanziEugen Trinka Systematic Review 24 July 2019 Pages: 771 - 781
Effects of Renal Impairment on the Pharmacokinetics of Once-Daily Amantadine Extended-Release Tablets Tina deVriesAngela DentisteDavid Jacobs Original Research Article Open access 24 July 2019 Pages: 783 - 789
Temporal Trends and Predictors of Drug Utilization and Outcomes in First-Ever Stroke Patients: A Population-Based Study Using the Singapore Stroke Registry See-Hwee YeoWai-Ping Yau Original Research Article 16 July 2019 Pages: 791 - 815
Objective Derivation of the Morphology and Staging of Visual Field Loss Associated with Long-Term Vigabatrin Therapy John M. WildPhilip E. M. SmithCarlo Knupp Original Research Article 27 June 2019 Pages: 817 - 829
Immune Globulin Subcutaneous (Human) 20% (Hizentra®): A Review in Chronic Inflammatory Demyelinating Polyneuropathy Yvette N. LambYahiya Y. SyedSohita Dhillon Adis Drug Evaluation 25 July 2019 Pages: 831 - 838
Correction to: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant Epilepsy Zeinab GharaylouAbbas TafakhoriMahmoudreza Hadjighassem Correction 23 July 2019 Pages: 839 - 839